Aurinia Pharmaceuticals Inc.
AUPH
$15.14
$0.231.54%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 31.55M | 21.51M | 23.34M | 1.43M | 14.35M |
| Total Depreciation and Amortization | 4.87M | 4.86M | 4.86M | 4.86M | 4.89M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.07M | 12.14M | -1.93M | 1.34M | 9.19M |
| Change in Net Operating Assets | 3.97M | 5.73M | -24.97M | 22.48M | -11.41M |
| Cash from Operations | 44.45M | 44.24M | 1.30M | 30.11M | 17.03M |
| Capital Expenditure | -65.00K | -98.00K | -17.00K | -281.00K | 140.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -13.71M | -13.18M | 31.05M | 39.50M | -10.71M |
| Cash from Investing | -13.77M | -13.27M | 31.03M | 39.22M | -10.57M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -3.45M | -3.43M | -2.77M | -3.03M | -2.96M |
| Issuance of Common Stock | 1.99M | 1.70M | 9.29M | 7.92M | 403.00K |
| Repurchase of Common Stock | -9.04M | -42.67M | -55.85M | -27.94M | -167.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -10.49M | -44.39M | -49.34M | -23.05M | -2.72M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 20.19M | -13.43M | -17.01M | 46.29M | 3.74M |